160 likes | 180 Views
The Future of Community Pharmacy: How pharmacies fit into the NHS Long Term Plan. Simon Dukes Pharmaceutical Services Negotiating Committee. The Future of Community Pharmacy. Pharmacies in England A five-year deal for pharmacy New services: CPCS and Hepatitis C
E N D
The Future of Community Pharmacy: How pharmacies fit into the NHS Long Term Plan Simon Dukes Pharmaceutical Services Negotiating Committee
The Future of Community Pharmacy • Pharmacies in England • A five-year deal for pharmacy • New services: CPCS and Hepatitis C • Supporting our NHS colleagues • Working within Primary Care Networks
Community Pharmacy: Key statistics • 11,600 pharmacies in England - Independents (1-5 pharmacies) 38% - Multiples (6+ pharmacies) 62% • 89% of the population can reach their local community pharmacy within a 20 minute walk • An estimated 1.6 million visits to pharmacies take place daily
Community Pharmacy: Key statistics • Over 90% of pharmacies now have a private consultation room • Community pharmacies are accessed by people who may not access other NHS services, helping to reduce health inequalities • NHS income for a typical community pharmacy accounts for 85% of their total turnover
The five-year CPCF agreement • PSNC negotiates with DHSC and NHS E&I • Deal fixes funding at £2.592bn per year from 2019/20 through to 2023/24 • Sets out the expansion of clinical service delivery through pharmacies, in line with the aims of the NHS Long Term Plan
Ambitions of the five-year agreement • Pharmacies will adapt to provide new services • The settlement will: “Expand and transform the role of community pharmacies and embed them as the first port of call for minor illness and health advice in England.” Matt Hancock, Secretary of State
Negotiations: Political Context • This was not the deal pharmacy wanted • We argued for further investment • Highlighted rising costs, threats to viability and the impact of cost-saving tactics • The deal secures future funding for as long as possible from Treasury, who are seeking efficiencies in dispensing • We believe it was the best deal available
What does this mean for pharmacies? • The deal guarantees a future for those pharmacies who are up for change • Specific challenges will be around: • dispensing efficiencies • freeing up pharmacists’ time • wider use of clinical workforce • branch viability and consolidations • coming together locally in PCNs • working closer with GPs
Two new national services in 2019/20 • The Community Pharmacist Consultation Service (CPCS) • Hepatitis C testing service Capacity being released through the decommissioning of MURs (replaced by structured clinical medication reviews)
Supporting NHS Colleagues: The Community Pharmacist Consultation Service (CPCS) • Helping people with minor illnesses and those needing urgent supplies of medicine • Pharmacist will provide healthcare adviceor assess whether an emergency supplyof medicine is appropriate • Onward referrals will be made if needed • GPs to be notified electronically
Supporting NHS Colleagues: The CPCS • Referrals initially to come from NHS 111 • Pilots to test expansion with referrals from GP practices (reception teams) • Increasing patient awareness of pharmacy as the ‘first port of call’ for minor illness • Reducing pressure on practices andurgent care providers • Supporting patients to self-managetheir health
Driving pharmacy clinical service development • Through the five-year deal, a range of pharmacy services will be piloted • If successful, these may be commissioned nationally in future years • The Pharmacy Integration Fund and the PCN Testbed programme are NHS development initiatives that will be used to provide the necessary funding for pilots
Reimbursement Changes and Consultation • PSNC, BMA and DDA worked on shared principles • Our response is principle-based: - Base prices on suppliers we purchase from - Remove dispensing at a loss - Fair distribution of margin - Certainty of reimbursement prior to dispensing - Smooth transition to new systems - Preventing any patient safety risks • Time to revisit generic substitution
Conclusions • Pharmacy’s new deal does much to integrate us with general practice • Supporting medicines safety, optimisation and prevention • CPCS: a new chance for us to help • Collaboration will be key – both at PCN and individual practice level
Contact Information psnc.org.uk cpcf@psnc.org.uk 0203 1220 810